Company: EDSA
Filing Date: 2025-03-04
Form Type: S-3
Source: 0001171843-25-001239
Chunk: 24

Company: Edesa Biotech, Inc.
Filing Date: 2025-03-04
Form: S-3
Chunk 24
---
 The address of the SEC’s website is www.sec.gov.

We make available free of charge on or through our
website at www.edesabiotech.com, our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments
to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, as soon as reasonably practicable after we
electronically file such material with or otherwise furnish it to the SEC.

We have filed with the SEC a registration statement
under the Securities Act, relating to the offering of these securities. The registration statement, including the attached exhibits, contains
additional relevant information about us and the securities. This prospectus does not contain all of the information set forth in the
registration statement. You can obtain a copy of the registration statement for free at www.sec.gov. The registration statement and the
documents referred to below under “Incorporation of Certain Information by Reference” are also available on our website, www.edesabiotech.com.

We have not incorporated by reference into this prospectus
the information on our website, and you should not consider it to be a part of this prospectus.

| 20 |

<div align='center'>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</div>

The SEC allows us to “incorporate by reference”
the information we have filed with it, which means that we can disclose important information to you by referring you to those documents.
The information we incorporate by reference is an important part of this prospectus, and later information that we file with the SEC will
automatically update and supersede this information. We incorporate by reference the documents listed below and any future documents (excluding
information furnished pursuant to Items 2.02 and 7.01 of Form 8-K) we file with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d)
of the Exchange Act, subsequent to the date of this prospectus and prior to the termination of the offering:

All reports and other documents that we file with the
SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this prospectus but before the termination of the offering
of the securities hereunder will also be considered to be incorporated by reference into this prospectus from the date of the filing of
these reports and documents, and will supersede the information herein;